Testing Methods of Screening for Woman Abuse in Health Care Settings.

Domestic Violence Clinical Trial

Official title:

Testing Screening Formats for Indicator-Based and Universal Screening Measurements in the Identification of Woman Abuse.

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00336297
• Other study ID #: MacMillan_VAW_Testing_Trial
• Status: Completed
• Phase: N/A
• First received: June 9, 2006
• Last updated: November 28, 2006
• Start date: May 2004
• Est. completion date: February 2005

Study information

• Verified date: February 2005
• Source: McMaster University
• Contact: n/a
• Is FDA regulated: No
• Health authority: Canada: Ethics Review Committee
• Study type: Interventional

Clinical Trial Summary

Recent reviews have identified the need for additional high quality exploratory and evaluative research to understand 1) the actual impact on all women of instituting mass screening procedures versus using indicator-based approaches to identifying woman abuse and 2) the extent to which early identification through screening -- either universal or indicator-based is effective in preventing or ameliorating important outcomes. This is a critical first step in developing a larger randomized controlled trial (RCT) which examines the effectiveness of screening in preventing woman abuse, improving quality of life and other associated outcomes. This study prepares for the RCT by testing the optimal method of administration for the two screening instruments that will be used in the RCT. The administration formats are: computer-based screen, paper and pencil screen and face-to-face screen. They study will also determine recruitment rates.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 2000
• Est. completion date: February 2005
• Gender: Female
• Age group: 18 Years to 64 Years

Eligibility

Inclusion Criteria:

• Women aged 18-64 years

• Patients at the health care site

• Able to participate in English

• Able to separate from accompanying person(s)

Exclusion Criteria:

• Too ill to participate

• Unable to separate from accompanying person(s)

• Unable to speak, read, or write English

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Prevention

Related Conditions & MeSH terms

• Domestic Violence

Intervention

Procedure:
• Woman Abuse Screening Tool

• Partner Violence Screen

• Computerized screening

• Face to face screening

• Written screening on forms

Locations

Country	Name	City	State
Canada	Cambridge Memorial Hospital - Emergency Department	Cambridge	Ontario
Canada	Carlisle Medical Centre	Carlisle	Ontario
Canada	City of Hamilton Public Health and Community Services Department	Hamilton	Ontario
Canada	Hamilton Health Sciences Colposcopy Clinic	Hamilton	Ontario
Canada	London Health Sciences - Victoria Hospital Clinic 5A	London	Ontario
Canada	Victoria Family Medical Centre	London	Ontario
Canada	Norfolk General Hospital - Emergency Department	Simcoe	Ontario

Sponsors (2)

Lead Sponsor	Collaborator
Hamilton Health Sciences Corporation	Ontario Women’s Health Council

Country where clinical trial is conducted

Canada, 

References & Publications (1)

MacMillan HL, Wathen CN, Jamieson E, Boyle M, McNutt LA, Worster A, Lent B, Webb M; McMaster Violence Against Women Research Group. Approaches to screening for intimate partner violence in health care settings: a randomized trial. JAMA. 2006 Aug 2;296(5): — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	disclosure rates for past year exposure to intimate partner violence
Secondary	participant satisfaction with completing the instruments
Secondary	missing data

External Links

•   Protocol for the subsequent RCT of effectiveness of screening for intimate partner violence.
•   Website of the McMaster University Violence Against Women Research Program.